An open-label, randomized, crossover study of comparative pharmacokinetics and bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg versus the combined use of Forxiga™, 10 mg and two Glucophage® Long, ER tablets, 500 mg co-administered to healthy volunteers under standard fed conditions
Primary Completion Date:
Study Completion Date:
Diabetes: Type 2
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Stay informed about new Trial Results Summaries with our email notification service